Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.79
-0.13 (-1.64%)
Apr 29, 2026, 12:39 PM EDT - Market open
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$1,499,972
Profits / Employee
$587,853
Market Cap
1.27B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| AbCellera Biologics | 562 |
| Wave Life Sciences | 317 |
| Viridian Therapeutics | 252 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| Olema Pharmaceuticals | 131 |
| ArriVent BioPharma | 77 |
NVAX News
- 21 days ago - Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy - Benzinga
- 21 days ago - Shah Capital intends to vote against Novavax's board nominees, executive compensation - Reuters
- 4 weeks ago - Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development - PRNewsWire
- 7 weeks ago - Novavax Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Novavax Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - What's Going On With Novavax Stock On Friday? - Benzinga
- 2 months ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb - Benzinga